Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

C. Trenkwalder,H. Benes̆,L. Grote,D. Garcia-Borreguero,B. Högl,M. Hopp,B. Bosse,A. Oksche,K. Reimer,J. Winkelmann,R. Allen,R. Kohnen
DOI: https://doi.org/10.1016/S1474-4422(13)70239-4
2013-12-01
Abstract:
What problem does this paper attempt to address?